Beqvez Side Effects
Generic name: fidanacogene elaparvovec
Note: This document provides detailed information about Beqvez Side Effects associated with fidanacogene elaparvovec. Some dosage forms listed on this page may not apply specifically to the brand name Beqvez.
Applies to fidanacogene elaparvovec: intravenous suspension.
Important warnings
This medicine can cause some serious health issues
This medicine may not work for every person who receives it.
Talk to your doctor if you have any questions.
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Some side effects may occur during or right after the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, unusual bleeding, or swelling in your face.
Common side effects may include:
-
abnormal liver tests.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
See also:
Hemgenix
Hemgenix (etranacogene dezaparvovec-drlb) is a gene therapy indicated for the treatment of adults ...
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Idelvion
Idelvion (coagulation factor ix recombinant, albumin fusion protein) is a long-acting, injectable ...
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
Alprolix
Alprolix is used in hemophilia B to help control and prevent bleeding, it is a coagulation Factor ...
BeneFix
BeneFix (coagulation factor IX) is a once-weekly, injectable, treatment for hemophilia B that may ...
NovoSeven RT
NovoSeven RT (coagulation Factor VIIa, recombinant) is an injectable, coagulation factor VIIa that ...
Rebinyn
Rebinyn (glycopegylated coagulation factor IX [recombinant]) is an injectable, long-lasting, human ...
For healthcare professionals
Applies to fidanacogene elaparvovec: intravenous suspension.
General adverse events
The most common adverse reaction was an increase in transaminases.[Ref]
Hepatic
- Very common (10% or more): Increased transaminases (up to 53.3%)[Ref]
Increased transaminases included increased ALT, increased AST, increased hepatic enzyme, abnormal hepatic function, abnormal liver function tests, and increased transaminases.[Ref]
References
1. (2024) "Product Information. Beqvez (upto 75 kg) (fidanacogene elaparvovec)." Pfizer U.S. Pharmaceuticals Group
More about Beqvez (fidanacogene elaparvovec)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
Patient resources
Professional resources
Related treatment guides
Further information
Beqvez side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.